Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan
· Delayed Price · Currency is TWD 71.30
-4.30 (-5.69%)
May 23, 2025, 1:30 PM CST
TPE:6657 Revenue
Energenesis Biomedical CO.,LTD. had revenue of 1.21M TWD in the quarter ending March 31, 2025, a decrease of -13.85%. This brings the company's revenue in the last twelve months to 7.55M, up 7.64% year-over-year. In the year 2024, Energenesis Biomedical CO.,LTD. had annual revenue of 7.75M with 8.26% growth.
Revenue (ttm)
7.55M
Revenue Growth
+7.64%
P/S Ratio
836.82
Revenue / Employee
n/a
Employees
35
Market Cap
6.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.75M | 591.00K | 8.26% |
| Dec 31, 2023 | 7.16M | -193.00K | -2.63% |
| Dec 31, 2022 | 7.35M | -138.00K | -1.84% |
| Dec 31, 2021 | 7.49M | 408.00K | 5.76% |
| Dec 31, 2020 | 7.08M | 830.00K | 13.28% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 87.67M |
| Oneness Biotech | 117.33M |
| Center Laboratories | 1.63B |
| Lumosa Therapeutics | 43.59M |